Last quarter (Q3 2023), Pacira Pharmaceuticals's total revenue was $163.93M, a decrease of -2.11% from the same quarter last year. In Q3, Pacira Pharmaceuticals's net income was $17.57M. See Pacira Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 665.69M	$ 666.82M	$ 541.53M	$ 429.65M	$ 421.03M	$ 337.28M
Cost of Revenue	$ 235.13M	$ 10.90M	$ 42.91M	$ 117.33M	$ 106.71M	$ 86.84M
Gross Profit	$ 413.94M	$ 655.92M	$ 498.62M	$ 312.32M	$ 314.31M	$ 250.43M
Operating Expense	$ 438.95M	$ 396.60M	$ 408.70M	$ 260.80M	$ 278.60M	$ 232.95M
Operating Income	$ 11.39M	$ 259.32M	$ 89.92M	$ 51.52M	$ 35.71M	$ 17.48M
Net Non Operating Interest Income Expense	$ -17.16M	$ -35.43M	$ -30.85M	$ -21.04M	$ -16.25M	$ -15.45M
Other Income Expense	$ 17.55M	$ 11.29M	$ 2.67M	$ -10.38M	$ -30.21M	$ -2.45M
Pretax Income	$ 9.91M	$ 13.30M	$ 56.40M	$ 20.09M	$ -10.75M	$ -425.00K
Tax Provision	$ 2.93M	$ -2.61M	$ 14.42M	$ -125.43M	$ 268.00K	$ 46.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ 13.70M	$ 15.91M	$ 41.98M	$ 145.52M	$ -11.02M	$ -471.00K
Basic EPS	$ 0.14	$ 0.35	$ 0.95	$ 3.41	$ -0.27	$ -0.01
Diluted EPS	$ 0.12	$ 0.34	$ 0.92	$ 3.33	$ -0.27	$ -0.01
Basic Average Shares	$ 183.97M	$ 45.52M	$ 44.26M	$ 42.67M	$ 41.51M	$ 40.91M
Diluted Average Shares	$ 196.61M	$ 46.54M	$ 45.63M	$ 43.68M	$ 41.51M	$ 40.91M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	$ 2.26	$ 1.70	$ 1.06
Reported Normalized Diluted E P S	-	-	-	$ 2.21	$ 1.67	$ 1.04
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 674.08M	$ 407.50M	$ 451.61M	$ 378.13M	$ 385.32M	$ 319.80M
Net Income From Continuing And Discontinued Operation	$ 6.98M	$ 15.91M	$ 41.98M	$ 145.52M	$ -11.02M	$ -471.00K
Normalized Income	$ 83.88M	-	-	$ 155.19M	$ 7.40M	$ 670.72K
Interest Expense	-	-	-	$ 23.52M	$ 21.92M	$ 20.32M
EBIT	$ 33.06M	$ 16.40M	$ 78.39M	$ 43.60M	$ 11.17M	$ 19.89M
EBITDA	$ 103.00M	$ 115.11M	$ 132.85M	$ 63.51M	$ 30.75M	$ 33.05M

Currency in USD

Pacira Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing